Seeking Alpha

JPMorgan calls today's weakness in GNC Holdings (GNC -4.4%) a "buying opportunity" after the FDA...

JPMorgan calls today's weakness in GNC Holdings (GNC -4.4%) a "buying opportunity" after the FDA warns about the dangers of stimulant DMAA. Analysts with the firm note that DMAA only makes up only a mid-single-digit percentage of GNC sales and the company plans to continue selling products with it despite the brouhaha.
Comments (1)
  • Diamond0000
    , contributor
    Comment (1) | Send Message
     
    Wont that affect GNC Tomorrow?
    30 Apr 2012, 05:10 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs